mesalamine has been researched along with Liver Diseases in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Liver Diseases: Pathological processes of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartleb, M | 1 |
| Biernat, L | 1 |
| Kochel, A | 1 |
| Shimamoto, M | 1 |
| Takewaki, S | 1 |
| Sakuraoka, S | 1 |
| Nagasawa, T | 1 |
| Kuroiwa, K | 1 |
| Kodama, O | 1 |
| Akatsuka, T | 1 |
1 review available for mesalamine and Liver Diseases
| Article | Year |
|---|---|
Drug-induced liver damage -- a three-year study of patients from one gastroenterological department.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agent | 2002 |
1 other study available for mesalamine and Liver Diseases
| Article | Year |
|---|---|
Use of L-leucyl-3-carboxy-4-hydroxyanilide as substrate for determining the activity of microsomal aminopeptidase in serum.
Topics: Aminopeptidases; Aminosalicylic Acids; Anilides; Biliary Tract Diseases; CD13 Antigens; Chromogenic | 1985 |